Home » Topics » BioWorld Science

BioWorld Science
RSS

SCLC subtypes have specific vulnerabilities

Jan. 22, 2021

Tau end run prevents memory deficits, but not inflammation

Jan. 22, 2021

First participants dosed in phase II study of MV-012-968

Jan. 22, 2021

Lyndra initiates phase I study of its rosuvastatin extended-release capsule

Jan. 22, 2021

Cell therapy targeting BCL11A gene safely induces erythrocyte fetal hemoglobin

Jan. 22, 2021

Codiak Biosciences describes extracellular vesicles targeting T cells

Jan. 22, 2021

U.S. IND application cleared for UX-701 gene therapy for Wilson disease

Jan. 22, 2021

FDA clears IND for phase II study of LTX-315

Jan. 22, 2021

EuBiologics receives IND approval in Korea for its COVID-19 vaccine candidate

Jan. 22, 2021

Target enrollment complete in diabetic foot ulcer study of SkinTE

Jan. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026